{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:40:44Z","timestamp":1790116844263,"version":"4.0.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013770","name":"Beihua University","doi-asserted-by":"publisher","award":["2024029"],"award-info":[{"award-number":["2024029"]}],"id":[{"id":"10.13039\/501100013770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["YDZJ202401109ZYTS"],"award-info":[{"award-number":["YDZJ202401109ZYTS"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.neuroscience.2025.01.045","type":"journal-article","created":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T12:24:53Z","timestamp":1737894293000},"page":"388-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Diverse pathways for the treatment of Parkinson\u2019s disease: Integration and development of traditional and emerging therapies"],"prefix":"10.1016","volume":"568","author":[{"given":"Yuanyuan","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2025.01.045_b0005","doi-asserted-by":"crossref","unstructured":"Alborghetti, M., Nicoletti, F.J.C.n., 2019. Different generations of type-B monoamine oxidase inhibitors in Parkinson\u2019s disease: from bench to bedside. 17, (9), 861-873.","DOI":"10.2174\/1570159X16666180830100754"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.01.045_b0010","first-page":"170","article-title":"The genetic architecture of","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Parkinson's Disease."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.01.045_b0015","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s10072-023-07233-6","article-title":"Objective assessment of the effects of opicapone in Parkinson's disease through kinematic analysis","volume":"45","author":"Bologna","year":"2024","journal-title":"Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"10","key":"10.1016\/j.neuroscience.2025.01.045_b0020","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0025","doi-asserted-by":"crossref","unstructured":"Chen, V.; Moncalvo, M.; Tringali, D.; Tagliafierro, L.; Shriskanda, A.; Ilich, E.; Dong, W.; Kantor, B.; Chiba-Falek, O. J. H. m. g., The mechanistic role of alpha-synuclein in the nucleus: impaired nuclear function caused by familial Parkinson\u2019s disease SNCA mutations. 2020, 29, (18), 3107-3121.","DOI":"10.1093\/hmg\/ddaa183"},{"issue":"24","key":"10.1016\/j.neuroscience.2025.01.045_b0030","first-page":"5394","volume":"186","author":"Chen","year":"2023","journal-title":"Circuit-Specific Gene Therapy Reverses Core Symptoms in a Primate Parkinson\u2019s Disease Model."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0035","first-page":"2055","volume":"41","author":"Chen","year":"2020","journal-title":"Research Advances on L-DOPA-Induced Dyskinesia: from Animal Models to Human Disease."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0040","doi-asserted-by":"crossref","first-page":"17845","DOI":"10.1038\/s41598-024-68609-y","article-title":"GDNF improves the cognitive ability of PD mice by promoting glycosylation and membrane distribution of DAT","volume":"14, (1)","author":"Chengcheng","year":"2024","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.01.045_b0045","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/brain\/awaa181","article-title":"Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa","volume":"143","author":"Cilia","year":"2020","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0050","doi-asserted-by":"crossref","unstructured":"d\u2019Angelo, M.; Cimini, A.; Castelli, V. J. I. J. o. M. S., Insights into the effects of mesenchymal stem cell-derived secretome in Parkinson\u2019s disease. 2020, 21, (15), 5241.","DOI":"10.3390\/ijms21155241"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0055","doi-asserted-by":"crossref","unstructured":"Daher, J. P. L. J. L.-r. r. k., Interaction of LRRK2 and \u03b1-Synuclein in Parkinson\u2019s Disease. 2017, 209-226.","DOI":"10.1007\/978-3-319-49969-7_11"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0060","doi-asserted-by":"crossref","unstructured":"De Luca, R.; Latella, D.; Maggio, M. G.; Leonardi, S.; Sorbera, C.; Di Lorenzo, G.; Balletta, T.; Cannav\u00f2, A.; Naro, A.; Impellizzeri, F. J. I. J. o. N., Do patients with PD benefit from music assisted therapy plus treadmill-based gait training? An exploratory study focused on behavioral outcomes. 2020, 130, (9), 933-940.","DOI":"10.1080\/00207454.2019.1710147"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0065","doi-asserted-by":"crossref","unstructured":"Ding, X.; Chen, Y.; Zhang, X.; Duan, Y.; Yuan, G.; Liu, C. J. N., Research progress on the protection and mechanism of active peptides in Alzheimer's disease and Parkinson's disease. 2024, 102457.","DOI":"10.1016\/j.npep.2024.102457"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0070","doi-asserted-by":"crossref","unstructured":"Fabbri, M.; Ferreira, J. J.; Rascol, O. J. C. d., COMT Inhibitors in the Management of Parkinson\u2019s Disease. 2022, 36, (3), 261-282.","DOI":"10.1007\/s40263-021-00888-9"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0075","doi-asserted-by":"crossref","unstructured":"Fan, S. Y.; Wang, K. L.; Hu, W.; Eisinger, R. S.; Han, A.; Han, C. L.; Wang, Q.; Michitomo, S.; Zhang, J. G.; Wang, F. J. A. o. c.; neurology, t., Pallidal versus subthalamic nucleus deep brain stimulation for levodopa\u2010induced dyskinesia. 2020, 7, (1), 59-68.","DOI":"10.1002\/acn3.50961"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0080","doi-asserted-by":"crossref","unstructured":"Fan, Y.; Winanto; Ng, S.-Y. J. T. N., Replacing what\u2019s lost: a new era of stem cell therapy for Parkinson\u2019s disease. 2020, 9, 1-10.","DOI":"10.1186\/s40035-019-0180-x"},{"issue":"23","key":"10.1016\/j.neuroscience.2025.01.045_b0085","first-page":"3822","volume":"11","author":"Fassler","year":"2022","journal-title":"A Single Chain Fragment Variant Binding Misfolded Alpha-Synuclein Exhibits Neuroprotective and Antigen-Specific Anti-Inflammatory Properties."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0090","doi-asserted-by":"crossref","unstructured":"Fodor, D. M.; Breda, X.-M.; Valean, D.; Marta, M. M.; Perju-Dumbrava, L. J. B. S., Music as add-on therapy in the rehabilitation program of parkinson\u2019s disease patients\u2014A Romanian pilot study. 2021, 11, (5), 569.","DOI":"10.3390\/brainsci11050569"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0095","doi-asserted-by":"crossref","unstructured":"Garcia-Ruiz, P. J.; Castrillo, J. C. M.; Alonso-Canovas, A.; Barcenas, A. H.; Vela, L.; Alonso, P. S.; Mata, M.; Gonzalez, N. O.; Fernandez, I. M. J. J. o. N., Neurosurgery; Psychiatry, Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study. 2014, 85, (8), 840-844.","DOI":"10.1136\/jnnp-2013-306787"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0100","doi-asserted-by":"crossref","unstructured":"George, S.; Hamblin, M. R.; Abrahamse, H. J. S. c. r.; reports, Differentiation of mesenchymal stem cells to neuroglia: in the context of cell signalling. 2019, 15, (6), 814-826.","DOI":"10.1007\/s12015-019-09917-z"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.01.045_b0105","first-page":"3906","volume":"142","author":"Georgiades","year":"2019","journal-title":"Hitting the Brakes: Pathological Subthalamic Nucleus Activity in Parkinson\u2019s Disease Gait Freezing."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0110","doi-asserted-by":"crossref","first-page":"e14797","DOI":"10.15252\/emmm.202114797","article-title":"Parkinson's disease motor symptoms rescue by CRISPRa-reprogramming astrocytes into GABAergic neurons","volume":"14, (5)","author":"Giehrl-Schwab","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0115","doi-asserted-by":"crossref","first-page":"1379496","DOI":"10.3389\/fpsyt.2024.1379496","article-title":"Modulation of time in Parkinson's disease: a review and perspective on cognitive rehabilitation","volume":"15","author":"Honma","year":"2024","journal-title":"Front. Psych."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0120","doi-asserted-by":"crossref","unstructured":"Jellinger, K. A., Is Braak staging valid for all types of Parkinson's disease? Journal of neural transmission (Vienna, Austria : 1996) 2019, 126, (4), 423-431.","DOI":"10.1007\/s00702-018-1898-9"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0125","first-page":"1","article-title":"The 20th anniversary of the first clinical use of Stalevo\u00ae. In Wiley Online","volume":"30","author":"Jenner","year":"2023","journal-title":"Library"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0130","doi-asserted-by":"crossref","unstructured":"Ji, H.; Zhang, Y.; Chen, C.; Li, H.; He, B.; Yang, T.; Sun, C.; Hao, H.; Zhang, X.; Wang, Y. J. J. o. N., D-dopachrome tautomerase activates COX2\/PGE2 pathway of astrocytes to mediate inflammation following spinal cord injury. 2021, 18, (1), 130.","DOI":"10.1186\/s12974-021-02186-z"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0135","first-page":"6","volume":"3","author":"Karayel","year":"2022","journal-title":"Proteome Profiling of Cerebrospinal Fluid Reveals Biomarker Candidates for Parkinson\u2019s Disease."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0140","doi-asserted-by":"crossref","unstructured":"Karim, M. R.; Liao, E. E.; Kim, J.; Meints, J.; Martinez, H. M.; Pletnikova, O.; Troncoso, J. C.; Lee, M. K. J. M. n., \u03b1-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment. 2020, 15, 1-18.","DOI":"10.1186\/s13024-020-00364-w"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.01.045_b0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.17116\/neiro201680636-41","article-title":"The preliminary results of subthalamic nucleus stimulation after destructive surgery in Parkinson's disease. Zhurnal voprosy neirokhirurgii imeni N","volume":"80","author":"Khabarova","year":"2016","journal-title":"N. Burdenko"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0150","doi-asserted-by":"crossref","unstructured":"Khabarova, E. A.; Denisova, N. P.; Dmitriev, A. B.; Slavin, K. V.; Verhagen Metman, L. J. B. s., Deep brain stimulation of the subthalamic nucleus in patients with Parkinson disease with prior pallidotomy or thalamotomy. 2018, 8, (4), 66.","DOI":"10.3390\/brainsci8040066"},{"issue":"10","key":"10.1016\/j.neuroscience.2025.01.045_b0155","article-title":"Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson\u2019s disease","volume":"30","author":"Kirkeby","year":"2023","journal-title":"STEM-PD."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.01.045_b0160","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s11910-023-01312-z","article-title":"Updates in Parkinson's disease integrative therapies: an evidence-based review","volume":"23","author":"Kola","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.01.045_b0165","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ncl.2021.11.002","article-title":"Surgery, stereotactic radiosurgery, and systemic therapy in the management of operable brain metastasis","volume":"40","author":"Kotecha","year":"2022","journal-title":"Neurol. Clin."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.01.045_b0170","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.celrep.2016.12.090","article-title":"PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival","volume":"18","author":"Lee","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0175","first-page":"7654798","article-title":"MicroRNA Expression Profiling Screen miR-3557\/324-Targeted CaMK\/mTOR in the Rat Striatum of Parkinson's Disease in Regular Aerobic Exercise","volume":"2019","author":"Liu","year":"2019","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0180","first-page":"4","volume":"10","author":"Liu","year":"2024","journal-title":"Transcriptomics Analyses of IL-1\u03b2-Stimulated Rat Chondrocytes in Temporomandibular Joint Condyles and Effect of Platelet-Rich Plasma."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0185","doi-asserted-by":"crossref","unstructured":"Mao, Z.; Ling, Z.; Pan, L.; Xu, X.; Cui, Z.; Liang, S.; Yu, X. J. F. i. a. n., Comparison of efficacy of deep brain stimulation of different targets in Parkinson's disease: a network meta-analysis. 2019, 11, 23.","DOI":"10.3389\/fnagi.2019.00023"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.01.045_b0190","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","article-title":"Current Clinical Applications of InVivo Gene Therapy with AAVs","volume":"29","author":"Mendell","year":"2021","journal-title":"Molecular Therapy : the Journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0195","doi-asserted-by":"crossref","unstructured":"Menon, S.; Armstrong, S.; Hamzeh, A.; Visanji, N. P.; Sardi, S. P.; Tandon, A. J. F. i. N., Alpha-synuclein targeting therapeutics for Parkinson's disease and related synucleinopathies. 2022, 13, 852003.","DOI":"10.3389\/fneur.2022.852003"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0200","doi-asserted-by":"crossref","unstructured":"Nagao, K.; Ding, C.; Ganga, G.; Alty, J. E.; Clissold, B. G.; McColl, C. D.; Reardon, K. A.; Schiff, M.; Kempster, P. A. J. P.; disorders, r., Inferring the long duration response to levodopa in Parkinson\u2019s disease. 2019, 60, 133-137.","DOI":"10.1016\/j.parkreldis.2018.09.002"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0205","doi-asserted-by":"crossref","unstructured":"Nam, Y.; Moon, G. J.; Kim, S. R. J. I. J. o. M. S., Therapeutic potential of AAV1-Rheb (S16H) transduction against neurodegenerative diseases. 2021, 22, (6), 3064.","DOI":"10.3390\/ijms22063064"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0210","volume":"177","author":"Naz","year":"2020","journal-title":"Ropinirole Silver Nanocomposite Attenuates Neurodegeneration in the Transgenic Drosophila Melanogaster Model of Parkinson's Disease."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.01.045_b0215","first-page":"649","volume":"128","author":"Newman","year":"2021","journal-title":"Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0220","doi-asserted-by":"crossref","unstructured":"Nicoletti, V.; Palermo, G.; Del Prete, E.; Mancuso, M.; Ceravolo, R. J. F. i. C.; Biology, D., Understanding the Multiple role of mitochondria in Parkinson\u2019s disease and related disorders: Lesson from genetics and protein\u2013interaction network. 2021, 9, 636506.","DOI":"10.3389\/fcell.2021.636506"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0225","doi-asserted-by":"crossref","unstructured":"Nimmo, J. T.; Verma, A.; Dodart, J.-C.; Wang, C. Y.; Savistchenko, J.; Melki, R.; Carare, R. O.; Nicoll, J. A. J. A. s. R.; Therapy, Novel antibodies detect additional \u03b1-synuclein pathology in synucleinopathies: potential development for immunotherapy. 2020, 12, 1-16.","DOI":"10.1186\/s13195-020-00727-x"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0230","doi-asserted-by":"crossref","first-page":"(16)","DOI":"10.3390\/ijms22169047","article-title":"Combination of Drugs and Cell Transplantation: More Beneficial Stem Cell-Based Regenerative Therapies Targeting Neurological Disorders","volume":"22","author":"Nishimura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.01.045_b0235","first-page":"1433","volume":"11","author":"Nori","year":"2018","journal-title":"Human Oligodendrogenic Neural Progenitor Cells Delivered with Chondroitinase ABC Facilitate Functional Repair of Chronic Spinal Cord Injury."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0240","doi-asserted-by":"crossref","unstructured":"Nozaki, T.; Sugiyama, K.; Asakawa, T.; Namba, H.; Yokokura, M.; Terada, T.; Bunai, T.; Ouchi, Y. J. J. o. N., Increased anteroventral striatal dopamine transporter and motor recovery after subthalamic deep brain stimulation in Parkinson\u2019s disease. 2021, 137, (2), 468-478.","DOI":"10.3171\/2021.10.JNS211364"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0245","first-page":"101","article-title":"Posture","volume":"87","author":"Park","year":"2021","journal-title":"Familiarity with Music Influences Stride Amplitude and Variability during Rhythmically-Cued Walking in Individuals with Parkinson\u2019s Disease."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.01.045_b0250","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.4103\/1673-5374.387976","article-title":"Effects of mesenchymal stem cell on dopaminergic neurons, motor and memory functions in animal models of Parkinson's disease: a systematic review and meta-analysis","volume":"19","author":"Park","year":"2024","journal-title":"Neural Regen. Res."},{"issue":"26","key":"10.1016\/j.neuroscience.2025.01.045_b0255","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMe2031151","article-title":"Parkinson's Disease - What's the FUS?","volume":"383","author":"Perlmutter","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.01.045_b0260","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mds.28382","article-title":"Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease","volume":"36","author":"Picillo","year":"2021","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0265","doi-asserted-by":"crossref","unstructured":"Pickar-Oliver, A.; Gersbach, C. A. J. N. r. M. c. b., The next generation of CRISPR\u2013Cas technologies and applications. 2019, 20, (8), 490-507.","DOI":"10.1038\/s41580-019-0131-5"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0270","doi-asserted-by":"crossref","unstructured":"Poewe, W.; Volc, D.; Seppi, K.; Medori, R.; L\u00fchrs, P.; Kutzelnigg, A.; Djamshidian, A.; Thun-Hohenstein, C.; Meissner, W. G.; Rascol, O. J. J. o. P. s. d., Safety and tolerability of active immunotherapy targeting \u03b1-synuclein with PD03A in patients with early Parkinson\u2019s disease: a randomized, placebo-controlled, phase 1 study. 2021, 11, (3), 1079-1089.","DOI":"10.3233\/JPD-212594"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/pharmaceutics14061252","article-title":"CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease","volume":"14","author":"Rahman","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0280","doi-asserted-by":"crossref","unstructured":"Raza, C.; Anjum, R. J. L. s., Parkinson's disease: Mechanisms, translational models and management strategies. 2019, 226, 77-90.","DOI":"10.1016\/j.lfs.2019.03.057"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0285","doi-asserted-by":"crossref","unstructured":"Ryan, E.; Seehra, G.; Sharma, P.; Sidransky, E. J. C. o. i. n., GBA1-associated parkinsonism: new insights and therapeutic opportunities. 2019, 32, (4), 589-596.","DOI":"10.1097\/WCO.0000000000000715"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41531-023-00589-8","article-title":"Comparative efficacy and safety of adjunctive drugs to levodopa for fluctuating Parkinson's disease - network meta-analysis","volume":"9, (1)","author":"Sako","year":"2023","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0295","doi-asserted-by":"crossref","unstructured":"Shejul, P. P.; Doshi, G. M. J. C. N. S. A. i. M. C., Glutamate Receptors and C-ABL Inhibitors: A New Therapeutic Approach for Parkinson's Disease. 2024, 24, (1), 22-44.","DOI":"10.2174\/0118715249268627231206115942"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.01.045_b0300","first-page":"119","volume":"145","author":"Shigematsu","year":"2022","journal-title":"Repeated Infusion of Autologous Adipose Tissue\u2010derived Stem Cells for Parkinson's Disease."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0305","doi-asserted-by":"crossref","unstructured":"Song, B.; Cha, Y.; Ko, S.; Jeon, J.; Lee, N.; Seo, H.; Park, K.-J.; Lee, I.-H.; Lopes, C.; Feitosa, M. J. T. J. o. c. i., Human autologous iPSC\u2013derived dopaminergic progenitors restore motor function in Parkinson\u2019s disease models. 2020, 130, (2), 904-920.","DOI":"10.1172\/JCI130767"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0310","doi-asserted-by":"crossref","first-page":"e16144","DOI":"10.1111\/ene.16144","article-title":"Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease","volume":"31, (2)","author":"Staubo","year":"2024","journal-title":"Eur. J. Neurol."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.01.045_b0315","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1021\/acschemneuro.1c00094","article-title":"The High Affinity Dopamine D(2) Receptor Agonist MCL-536: a new tool for studying dopaminergic contribution to neurological disorders","volume":"12","author":"Subburaju","year":"2021","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0320","doi-asserted-by":"crossref","unstructured":"Sun, C.; Armstrong, M. J. J. B. s., Treatment of Parkinson\u2019s disease with cognitive impairment: current approaches and future directions. 2021, 11, (4), 54.","DOI":"10.3390\/bs11040054"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0325","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720908512","article-title":"GDNF Promotes Survival and Therapeutic Efficacy of Human Adipose-Derived Mesenchymal Stem Cells in a Mouse Model of Parkinson's Disease","volume":"29","author":"Sun","year":"2020","journal-title":"Cell Transplant."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0330","doi-asserted-by":"crossref","unstructured":"Svensson, K. A.; Hao, J.; Bruns, R. F. J. A. i. p., Positive allosteric modulators of the dopamine D1 receptor: a new mechanism for the treatment of neuropsychiatric disorders. 2019, 86, 273-305.","DOI":"10.1016\/bs.apha.2019.06.001"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0335","doi-asserted-by":"crossref","unstructured":"Tan, Y.-Y.; Jenner, P.; Chen, S.-D. J. J. o. P. s. D., Monoamine oxidase-B inhibitors for the treatment of Parkinson\u2019s disease: past, present, and future. 2022, 12, (2), 477-493.","DOI":"10.3233\/JPD-212976"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0340","doi-asserted-by":"crossref","unstructured":"Temel, Y.; Blokland, A.; Steinbusch, H. W.; Visser-Vandewalle, V. J. P. i. n., The functional role of the subthalamic nucleus in cognitive and limbic circuits. 2005, 76, (6), 393-413.","DOI":"10.1016\/j.pneurobio.2005.09.005"},{"issue":"11","key":"10.1016\/j.neuroscience.2025.01.045_b0345","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41575-020-0339-z","article-title":"Parkinson disease and the gut: new insights into pathogenesis and clinical relevance","volume":"17","author":"Travagli","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.01.045_b0350","first-page":"591","volume":"19","author":"Volc","year":"2020","journal-title":"Safety and Immunogenicity of the \u03b1-Synuclein Active Immunotherapeutic PD01A in Patients with Parkinson's Disease: a Randomised, Single-Blinded, Phase 1 Trial"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0355","doi-asserted-by":"crossref","unstructured":"Weihofen, A.; Liu, Y.; Arndt, J. W.; Huy, C.; Quan, C.; Smith, B. A.; Baeriswyl, J.-L.; Cavegn, N.; Senn, L.; Su, L. J. N. o. d., Development of an aggregate-selective, human-derived \u03b1-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models. 2019, 124, 276-288.","DOI":"10.1016\/j.nbd.2018.10.016"},{"issue":"7844","key":"10.1016\/j.neuroscience.2025.01.045_b0360","first-page":"22","volume":"590","author":"Willyard","year":"2021","journal-title":"How Gut Microbes Could Drive Brain Disorders."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0365","doi-asserted-by":"crossref","unstructured":"Woitalla, D.; Kr\u00fcger, R.; Lorenzl, S.; M\u00fcller, T.; Oelwein, G.; Storch, A.; Wolz, M.; W\u00fcllner, U. J. F. d. N.-p., The role of inhibitors of COMT and MAO-B in the therapy of Parkinson's disease. 2020, 88, (9), 620-633.","DOI":"10.1055\/a-1149-9308"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.01.045_b0370","first-page":"188","volume":"18","author":"Wood","year":"2022","journal-title":"N., \u03b1-Synuclein-Activated Microglia Are Implicated in PD Pathogenesis."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0375","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13024-022-00553-9","article-title":"Combination therapy using GDNF and cell transplant in Parkinson's disease","volume":"17, (1)","author":"Xiao","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0380","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12031-024-02254-y","article-title":"GDNF's Role in Mitigating Intestinal Reactive Gliosis and Inflammation to Improve Constipation and Depressive Behavior in Rats with Parkinson's disease","volume":"74, (3)","author":"Xiaoling","year":"2024","journal-title":"Journal of Molecular Neuroscience : MN"},{"issue":"1179","key":"10.1016\/j.neuroscience.2025.01.045_b0385","first-page":"4","article-title":"LRRK2 G2019S and Parkinson\u2019s disease","volume":"100","author":"Yao","year":"2024","journal-title":"Insight from Neuroinflammation."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0390","doi-asserted-by":"crossref","unstructured":"Yoon, Y.; Kim, H. S.; Hong, C. P.; Li, E.; Jeon, I.; Park, H. J.; Lee, N.; Pei, Z.; Song, J. J. F. i. n., Neural transplants from human induced pluripotent stem cells rescue the pathology and behavioral defects in a rodent model of Huntington\u2019s disease. 2020, 14, 558204.","DOI":"10.3389\/fnins.2020.558204"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0395","doi-asserted-by":"crossref","unstructured":"Zhang, Y.; Liu, Z.; Wang, K.; Lu, S.; Fan, S.; Xu, L.; Cai, B. J. I. J. o. B. S., Macrophage migration inhibitory factor regulates joint capsule fibrosis by promoting TGF-\u03b21 production in fibroblasts. 2021, 17, (7), 1837.","DOI":"10.7150\/ijbs.57025"},{"key":"10.1016\/j.neuroscience.2025.01.045_b0400","doi-asserted-by":"crossref","unstructured":"Zhang, Y.; Wang, T.; Zhang, D.; Li, J.; Yue, X.; Kong, W.; Gu, X.; Jiao, Z.; Yang, C. J. F. i. B.; Biotechnology, Thermosensitive hydrogel loaded with concentrated growth factors promote bone repair in segmental bone defects. 2022, 10, 1039117.","DOI":"10.3389\/fbioe.2022.1039117"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.01.045_b0405","first-page":"5804","volume":"13","author":"Zhang","year":"2021","journal-title":"Macrophage Migration Inhibitory Factor Activates the Inflammatory Response in Joint Capsule Fibroblasts following Post-Traumatic Joint Contracture."},{"key":"10.1016\/j.neuroscience.2025.01.045_b0410","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11033-024-09294-y","article-title":"Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson's disease","volume":"51, (1)","author":"Zhang","year":"2024","journal-title":"Mol. Biol. Rep."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225000570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225000570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:44:01Z","timestamp":1777265041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225000570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":82,"alternative-id":["S0306452225000570"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.01.045","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diverse pathways for the treatment of Parkinson\u2019s disease: Integration and development of traditional and emerging therapies","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.01.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}